相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes
Balazs Gyorffy et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Targeting microRNAs as key modulators of tumor immune response
Laura Paladini et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer
Tejal Joshi et al.
ONCOTARGET (2016)
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
Magali Michaut et al.
SCIENTIFIC REPORTS (2016)
AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients
Giulia Bottai et al.
NPJ BREAST CANCER (2016)
Integrative network-based approach identifies key genetic elements in breast invasive carcinoma
Mohamed Hamed et al.
BMC GENOMICS (2015)
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment
F. J. Kohlhapp et al.
ONCOGENE (2015)
Oncostatin M activates STAT3 to promote endometrial cancer invasion and angiogenesis
Minjiao Zhu et al.
ONCOLOGY REPORTS (2015)
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer
Maija Hollmen et al.
SCIENTIFIC REPORTS (2015)
Identification and consequences of miRNA-target interactions - beyond repression of gene expression
Jean Hausser et al.
NATURE REVIEWS GENETICS (2014)
Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer
N. R. West et al.
ONCOGENE (2014)
Macrophages are recruited to hypoxic tumor areas and acquire a Pro-Angiogenic M2-Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin
Chakrapani Tripathi et al.
ONCOTARGET (2014)
Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling
Xiaofeng Dai et al.
SCIENTIFIC REPORTS (2014)
Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator
Philip Vlaicu et al.
BMC CANCER (2013)
Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control
Emanuele de Rinaldis et al.
BMC GENOMICS (2013)
Tackling the Diversity of Triple-Negative Breast Cancer
Nicholas C. Turner et al.
CLINICAL CANCER RESEARCH (2013)
A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells
Daya Luo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition
L. Guo et al.
ONCOGENE (2013)
DNARepair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes
Libero Santarpia et al.
ONCOLOGIST (2013)
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers
Libero Santarpia et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer
Nathan R. West et al.
ENDOCRINE-RELATED CANCER (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
Vessela N. Kristensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
Francesca M. Buffa et al.
CANCER RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer
Takayuki Iwamoto et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
Francoise Rothe et al.
PLOS ONE (2011)
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Cherie Blenkiron et al.
GENOME BIOLOGY (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Oncostatin M induces cell detachment and enhances the metastatic capacity of T-47D human breast carcinoma cells
Cheryl L. Jorcyk et al.
CYTOKINE (2006)
Breast cancer cells stimulate neutrophils to produce oncostatin M: Potential implications for tumor progression
MM Queen et al.
CANCER RESEARCH (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)